DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 04 · Volume 32 · July 1999 DOI: 10.1055/s-002-6187

Editorial

117
Pharmapsychiatry Intends to Follow the CONSORT-Statement for Future Reviewing of Submitted Manuscripts

Original Papers

119
Boerner, R. J.; Möller, H. J.: The Importance of New Antidepressants in the Treatment of Anxiety/Depressive Disorders
127
Rüther, E.; Degner, D.; Munzel, U.; Brunner, E.; Lenhard, G.; Biehl, J.; Vögtle-Junkert, U.: Antidepressant Action of Sulpiride. Results of a Placebo-Controlled Double-Blind Trial
136
Perugi, G.; Toni, C.; Ruffolo, G.; Sartini, S.; Simonini, E.; Akiskal, H.: Clinical Experience Using Adjunctive Gabapentin in Treatment-Resistant Bipolar Mixed States
142
Ferszt, R.; Kühl, K.-P.; Bode, L.; Severus, E. W.; Winzer, B.; Berghöfer, A.; Beelitz, G.; Brodhun, B.; Müller-Oerlinghausen, B.; Ludwig, H.: Amantadine Revisited: An Open Trial of Amantadinesulfate Treatment in Chronically Depressed Patients with Borna Disease Virus Infection
148
Szegedi, A.; Anghelescu, I.; Wiesner, J.; Schlegel, S.; Weigmann, H.; Härtter, S.; Hiemke, Ch.; Wetzel, H.: Addition of Low-Dose Fluvoxamine to Low-Dose Clozapine Monotherapy in Schizophrenia: Drug Monitoring and Tolerability Data from a Prospective Clinical Trial

Case Reports

154
Steinwachs, A.; Grohmann, R.; Pedrosa, F.; Rüther, E.; Schwerdtner, I.: Two Cases of Olanzapine-lnduced Reversible Neutropenia
157
Michael, A.; Calloway, S. P.: Priapism in Twins
158
Bschor, T.: Complete Suppression of Recurrent Herpes Labialis with Lithium Carbonate

Letters to the Editor

159
Breyer-Pfaff, U.: Norharman - is it an Exclusively Endogenous Modulator of Behavior?
160
Reply of the Autors